Kazakhstan vs Upper-middle income (World Bank): Cases started on MDR-TB treatment
Kazakhstan
4,641
in 2024
Upper-middle income (World Bank)
47,920
in 2024
Kazakhstan rank
7th
Upper-middle income (World Bank) rank
4th
Cases started on MDR-TB treatment over time
- Kazakhstan
- Upper-middle income (World Bank)
How they compare
Upper-middle income (World Bank) currently reports 47,920 against 4,641 in Kazakhstan, a difference of 43,279.
That makes Upper-middle income (World Bank)'s figure about 10.3 times Kazakhstan's.
Across all 16 years both countries report, Upper-middle income (World Bank) has been ahead every year.
Kazakhstan ranks 7th and Upper-middle income (World Bank) ranks 4th of 193 countries.
Upper-middle income (World Bank) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,209 | 15,623 | 12,414 | Upper-middle income (World Bank) |
| 2010s | 6,228 | 38,099 | 31,871 | Upper-middle income (World Bank) |
| 2020s | 4,665 | 46,227 | 41,562 | Upper-middle income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Kazakhstan or Upper-middle income (World Bank)?
- Upper-middle income (World Bank), at 47,920 against 4,641 in Kazakhstan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Kazakhstan and Upper-middle income (World Bank)?
- 43,279, with Upper-middle income (World Bank) ahead.
- How many years of comparable data are there for Kazakhstan and Upper-middle income (World Bank)?
- 16 years are reported by both, from 2009 to 2024.
- How do Kazakhstan and Upper-middle income (World Bank) rank globally for cases started on mdr-tb treatment?
- Kazakhstan ranks 7th and Upper-middle income (World Bank) ranks 4th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.